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Abstract
Background: Tuberculosis (TB) is the second greatest killer worldwide that is caused by a single infectious agent.
For its control, studies of TB vaccines are needed. Since Bacillus Calmette-Guerin (BCG) is the only vaccine against
TB currently in use, studies addressing the protective role of BCG in the context of inducible inflammatory
mediators are urgently required.
Methods: In this study, groups of HIV-negative adult healthy donors (HD; n = 42) and neonates (UV; n = 18) have
been voluntarily enrolled, and BCG Moreau strain was used for the in vitro mononuclear cell infections for an initial
period of 48 h. Subsequently, harvested conditioned medium (CM) was added to autologous resting cells for an
additional 24, 48, and 120 h, and Annexin V, in conjunction with a vital dye, was then used for apoptosis detection.
CM was also assayed for nitric oxide (NO), prostaglandin E2 (PGE2), leukotriene B4 (LTB4), interferon (IFN)-β, and
transforming growth factor (TGF)-β1 levels. The p values were set up for any differences between two groups of
individuals using Student’s t-test and considered significant when ≤ 0.05.
Results: At 120 h, CM induced the highest apoptosis levels in both group studied, but necrosis was high in UV
group only (p-value < 0.05). NO was released equally during BCG infection in both groups, but higher levels were
found in HD when compared with UV group (p-value < 0.05). Overall, BCG Moreau triggered high PGE2, LTB4 and
IFN-β productions in macrophages from the UV group (p-value ≤ 0.05), whereas the prostanoid PGE2 and TGF-β1
had an opposite pattern in the HD group.
Conclusions: This study uncovers critical roles for endogenous compounds in the instruction of host macrophage
cell death patterns. Understanding the regulation of human immune responses is critical for vaccine development
and the treatment of infectious diseases. These findings shed new light on the potential condition for a booster
immunization in individuals already vaccinated with BCG for TB protection, and further studies are warranted.
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Background
Despite the continuous evolution of better management,
new drug development, and additional diagnostic tools
available in public health, tuberculosis (TB) still remains
as a serious global problem. There were a total of 8.6
million new cases and 1.3 million deaths in 2012; TB
is a leading killer of people living with HIV [1]. It is
currently estimated that one third of the world popu-
lation is infected with Mycobacterium tuberculosis and
that 5–10 % of those infected will develop the disease
during their life-time [2].
The current TB vaccine is M. bovis bacille Calmette-
Guérin (BCG), and it has been employed for nearly a
century to prevent the disease. However, while BCG is
the most common and broadly used vaccine worldwide,
its efficacy remains quite controversial: In endemic sites,
the vaccine has evoked unpredictable outcomes [3]. Epi-
demiological studies point to BCG as affording more
complete protection against the meningeal and miliary
clinical forms of TB in children than against the pul-
monary clinical form in adults (Reviewed by [4]). It is
generally perceived that the BCG vaccine is not fully
effective because of the absence of antigens commonly
shared with M. tuberculosis, but also that the rapid
removal of BGC via systemic immunity, primarily tar-
geting atypical environmental mycobacteria, reduces
the vaccine’s effectiveness over time. Therefore, more
studies are required to better understand how BCG
confers protection in humans.
Conventional studies have focused solely on the role of
cytokines released by monocytes infected with BCG as a
starting point for inducing immunity, such as the pro-
inflammatory interleukin 1 beta (IL-1β) and tumor necro-
sis factor alpha (TNF-α) (Reviewed by [5, 6]). Thus, one of
the issues raised concerns the additional soluble com-
pounds that are potentially secreted by host cells during
BCG infection. Also, there may be a later increase in those
factors for the initiation of apoptosis, necrosis, necroptosis
and pyroptosis. The action of inflammatory caspases, such
as caspase-1, has shown promising results for the ac-
tivation of IL-1β through an inflammasome mechan-
ism during microbial pathogens interactions [7].
Our prior study supports the hypothesis that BCG in-
duces distinct cell-death patterns during the maturation
of the immune system [8]. In the study, we observed in-
creasing apoptosis in BCG-stimulated monocytes from
healthy, vaccinated adults, associated with a release of
IL-1β and TNF-α, but not with metalloproteinase-9.
Conversely, higher monocyte necrosis, but not apoptosis,
was observed following the infection of umbilical vein
cells from naïve neonates. This pattern was paralleled by
different pro-inflammatory cytokine levels when com-
pared to adults. In addition, necrosis has been defined as a
mechanism used by virulent bacteria to exit macrophages,
evade the host defenses, and disseminate; apoptosis has
been associated with diminished pathogen viability [9, 10].
To address remaining critical issues beyond these
premises, we have constructed a model of conditioned
cell culture medium, i.e., culture supernatants obtained
from host cells infected with BCG for 48 h, for the study
of the factors secreted by those cells that potentially are
responsible for monocyte cell-death during the context
of infection. Our hypothesis has a basis in compelling
evidence from one recent study where eicosanoid lipid
intermediaries regulated the cell death program of hu-
man macrophages infected with M. tuberculosis [10].
Thus, a cross-sectional population study of samples
from Brazil was the means to uncover critical aspects of
the in vitro degree of apoptosis and necrosis induced by
BCG Moreau in monocytes from individuals, whether
sensitized (adults) or non-sensitized (neonates). Using
this method, there is input for a better understanding of
the protective factors afforded by BCG against TB that
would help to identify the processes by which this
protection is achieved, thus opening up a horizon for
its future improved clinical applicability.
Methods
Study participants
Between November 2010 and August 2012, two groups of
donors were enrolled for this study at the Gaffrée Guinle
State University Hospital of Rio de Janeiro (HUGG):
healthy donor adults (HD; a total of 42 individuals) from
the blood bank (anonymous donation policy, but included
individuals age ≥ 18-years old), and healthy mothers who
participated in procedures to puncture umbilical cords
and obtain blood samples from newborns’ umbilical
vein (UV; a total of 18 neonates). Inclusion and ex-
clusion criteria for those HIV-seronegative individuals
are described elsewhere [8]. The HUGG Institutional
Review Board approved this study under protocols
#060/2009 and #089/2011. All participants in this
study provided written informed consent.
Mononuclear cells purification, culture, in vitro infection
with BCG and cell death assay
The peripheral blood mononuclear cells (PBMC) and
cord blood mononuclear cells (CBMC) were separated,
cultured, and infected with M. bovis BCG Moreau strain
for 48 h as previously described [8]. Cell cultures (1 × 106)
were used at a multiplicity of infection (MOI) of 2:1 (bacil-
li:mononuclear cell). The bacilli viability was promptly
assessed by a commercially available LIVE/DEAD Bac-
Light bacterial viability kit (Life Techonologies, Carlsbad,
CA, USA) in combination with flow cytometry. Next,
the cell-free supernatants, henceforth called conditioned
medium (CM), were collected, passed through a 0.22 μm
pore size filter (Millipore, Bedford, MA, USA), and instantly
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transferred (700 μl) to either autologous resting PBMC or
CBMC (1 × 106) for an additional 24, 48, and 120 h. This
followed a protocol similar to that of Nagabhusha-
nam and colleagues [11]. Subsequent to incubation, cells
were labeled using an apoptosis detection kit as specified
by the manufacturer (TACS, R&D systems, Minneapolis,
MN, USA) and immediately analyzed in a flow cytometer
device (FACScalibur, BD, San Jose, CA, USA). Those tubes
designated as negative control (baseline) remained unin-
fected for the whole period of time. Other tubes designated
as positive control consisted of cells subjected to a heating
and boiling cycle just before staining in order to force cell
necrosis [8]. A parallel process was used to establish the
human acute monocytic leukemia cell line THP-1 (Kindly
provided by Dr. M. C. V. Pessolani, FIOCRUZ, Brazil) in a
monocyte-like state. Cells were grown, expanded, cultured
in tubes (1 × 106), and then infected with M. bovis
BCG Moreau strain (MOI of 2:1) for 48 h. Next, cells
were labeled and analyzed following the same apoptosis
detection protocol as previously described.
NO indirect detection by chemical test
A modified Griess diazotization reaction for microassay
detection of the presence of organic nitrite compounds,
such as nitric oxide (NO), was used in thawed cell-free
supernatants (or frozen CM) as previously described [12].
PGE2, LTB4, IFN-β, TGF-β1 detection by ELISA
Prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), inter-
feron (IFN)-β, and transforming growth factor (TGF)-β1
levels were determined in thawed cell-free supernatants
(or frozen CM) using commercially available enzyme
linked immunosorbent assay (ELISA) kits (Invitrogen
Corp., Carlsbad, CA, USA; TFB Inc., Tokyo, Japan; and
DuoSet, R&D systems, Minneapolis, MN, USA, respect-
ively). The immunoassays were carried out according to the
manufacturer instructions. The detection limits were 30 pg/
ml (PGE2), 8 pg/ml (LTB4), 3.1 pg/ml (IFN-β), and 20 pg/ml
(TGF-β1). For comparison purposes only, a thawed CM
from BCG-infected mononuclears at 24 h was also included
as an earlier time-point in both groups studied.
Statistical evaluation
Data were analyzed using Instat Statistical software, ver-
sion 3.06 for Windows (GraphPad Software Inc., La
Jolla, CA, USA). The significance of the difference in
levels of immune responses between the two groups of
individuals was calculated using the Student’s t-test. The
THP-1 cell-death levels were represented as the mean ±
standard error of the mean (SEM). The p-value was
scored and considered significant when ≤ 0.05.
Results
Cell-Death ratio
A better understanding of the pathways related to the in
vitro cell-mediated immune responses in humans has
been obtained for individuals, BCG-sensitized or not,
which will assist in identifying the specific mechanisms
that may confer protection against M. tuberculosis. To
this end, and also based on our previous findings [8], we
enrolled two groups of donors representing distinct im-
munity characteristics due to previous exposure to
mycobacterial antigens. The first group consisted of
healthy donor adults (HD) who had been already vacci-
nated with BCG Moreau during childhood. [Note: BCG
vaccination in Brazil is universal after birth since 1967].
The second group consisted of naïve individuals (i.e. ne-
onates) who had never been exposed to mycobacteria;
Umbilical vein (UV) cells from the naive individuals
were promptly collected after their delivery. After standard
experimental procedures [8], CM resembling cell-free
supernatant was generated from 48 h BCG Moreau-
infected cells (bacilli viability > 90 %), and the autologous
remaining resting cultures were further incubated
with CM for additional 24, 48 and 120 h. Baseline
cultures with no stimuli for a total of 168 h were
used as a single negative control, since matched, earlier
time-frames showed negligible differences. Cell-death
events were analyzed to detect apoptosis and necrosis
following an identical protocol described earlier [8].
Table 1 summarizes those findings.
We observed a significant increase in apoptosis
(p-value < 0.05) when CM was placed in contact with
resting cells from both groups of individuals for an
extended 120 h, as compared to the baseline, nega-
tive control. Moreover, only cells from UV group
showed an increase in necrosis (p-value < 0.05) under
the same conditions and incubation periods. Curi-
ously, in shorter experimental time-frames, there
were no cell-death compared with negative control
in both groups studied (Table 1). In addition, and in
Table 1 Specific cell-death (%) in monocytes of healthy
donor (HD, n = 16) and umbilical vein (UV, n = 5) groups after
transference of conditioned medium (CM)
Apoptosis Necrosis
HD UV HD UV
Negative control 32.5 ± 4.2a 12.7 ± 2.1 12.2 ± 2.5 3.4 ± 1.1
CM 24 h 30.5 ± 4.5 14.8 ± 1.2 13.1 ± 2.0 2.4 ± 0.4
CM 48 h 36.1 ± 4.1 12.5 ± 1.8 12.7 ± 2.1 2.4 ± 0.5
CM 120 h 57.2 ± 3.6b 22.1 ± 1.4b 12.4 ± 1.7 9.0 ± 1.3b
Positive controlc 31.8 ± 5.4 59.7 ± 4.7b 57.4 ± 5.3b 36.2 ± 4.8b
aMean ± SEM;
bp < 0.05, when compared to negative control (baseline);
cHeating samples was used to artificially induce necrosis
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opposition to the results described previously, the
heating cycle caused an enhancement in apoptosis
(p-value < 0.05) only in the UV group, although ne-
crosis (p-value < 0.05) was the highest in both groups,
as expected.
With the aim of clarifying whether most of the pri-
mary monocytes increase in cell-death levels occurred
after the M. bovis BCG infection, we used a smaller set
of experiments (n = 6) to test the THP-1 cell-line in our
in vitro model. This step allowed us to confirm the
previous results in primary mononuclear cell cultures
(17.1 ± 1.0 and 24.7 ± 0.6; 6.5 ± 0.6 and 17.6 ± 0.8, at
baseline and 48 h of BCG-infected THP-1 cell-line
conditions for apoptosis and necrosis, respectively:
p-values < 0.01). Thus, the THP-1 cell-line mirrored
the cell-death patterns after BCG infection found
particularly in the UV group studied.
Additionally, we attempted to better characterize the
CM constituents in the next assays.
Nitric Oxide levels
The production of NO by host innate immune cells is
recognized to be a successful defense against infection,
but the specific mechanism by which NO antagonize the
pathogen, involving induction of apoptosis in macro-
phages that harbor the mycobacteria, is not completely
understood [13, 14]. In addition, IL-1β, TNF-α, and
mycobacterial cell wall components, along with T-cell-
derived IFN-γ, may also induce NO release. Thus, NO
released during 48 h-BCG infection in both PBMC and
CBMC cultures (the frozen CM) were assayed, and the
highest levels (p-value < 0.01) were found only in the HD
when compared with UV group (Fig. 1).
Inflammatory lipid mediators and cytokines levels
At an early encounter with noxious stimuli, the host
produces a nonspecific inflammatory response, but a
more specific immune response is believed to be modu-
lated by two classes of molecules: eicosanoid lipid inter-
mediaries, such as PGE2 and LTB4, and cytokines,
synthesized by phagocytes [15]. A preceding study has
associated increased prostanoid PGE2 levels with apop-
tosis, as well as high pronecrotic lipid mediators, such as
LTB4 and necrosis [10]. Similarly, IFN-β levels were
shown to be elevated in necrosis [16] and necroptosis as
well [17]. Importantly, increased PGE2 concentrations
have been found in TB patients compared to HD and/or
latent TB infected patients [18]. In order to uncover crit-
ical aspects of cell-death modality induced by BCG Mo-
reau and to corroborate any potential link of those
ecosanoids and IFN-β with our in vitro cell-death sys-
tem, competitive ELISA to the eicosanoids (Fig. 2), and
ordinary ELISA to IFN-β and TGF-β1 were assayed
(Fig. 3). When group means and dispersions for PGE2 in
BCG-infected mononuclears were individually compared
at 24 and 48 h to the baseline, a similar pattern was
found in both groups studied (Fig. 2). However, the
highest levels were achieved at 48 h only (p-value <
0.05). On the other hand, LTB4 was exclusively induced
in UV group (p-value < 0.05; Fig. 2), whereas only a trend
for higher levels after 24 h of the BCG-infected cells in
the HD group was found (p-value = 0.08). In addition,
the highest IFN-β levels (p-value ≤ 0.05) did follow the
ecosanoids pattern for the UV group only, but TGF-β1
levels behaved as an opposite manner when compared
to PGE2 in HD group, i.e. a drop in concentration after
BCG-infected mononuclears (p-value ≤ 0.05; Fig. 3). Of
note, when dispersions were compared between the 2
groups studied despite stimulus, UV group showed min-
imal range for TGF-β1 levels. Besides, in order to highlight
overall variations and particular changes to those soluble
mediators at the individual donor level, connecting lines
were built and thus allowed the visualization for a trend to
mostly individuals tested (Additional file 1: Figure S1).
Discussion
Prophylactic medicine via vaccination is still the most
cost effective means to reduce the spread of infectious
diseases, and it also minimizes the burden on the health
system. Because TB has imposed centuries-long threat
to humans, the majority of the population in the tropics
has been immunized with BCG in the infancy, but real
protection against disease during adulthood has not yet
been achieved. There is a long road ahead to better
understand the entire clinical utility of BCG Moreau




Fig. 1 Nitric Oxide (NO) levels (mM) in healthy donor (HD; n = 6)
and umbilical vein (UV; n = 8) groups representing baseline and 48 h
of in vitro BCG Moreau infection in human mononuclears. Horizontal
bars represent mean NO values in each condition. **p < 0.01
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Fig. 2 Prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) activity levels (%) in healthy donor (HD; n = 36) and umbilical vein (UV; n = 17) groups
representing baseline and different times of in vitro BCG Moreau infection in human mononuclears. Horizontal bars represent mean values in
each condition. *p≤ 0.05
IU
Fig. 3 Transforming growth factor (TGF)-β1 levels (pg/ml) and Interferon (IFN)-β levels (IU/ml) in healthy donor (HD; n = 42) and umbilical vein
(UV; n = 18) groups representing baseline and different times of in vitro BCG Moreau infection in human mononuclears. Horizontal bars represent
mean values in each condition. *p≤ 0.05
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Here, consistent data have shown an enhancement of
the in vitro apoptosis rate in monocytes from both adult
and neonate individuals only after repeated long-term
incubation with CM from autologous, infected BCG
Moreau cultures that have been regularly used in a pre-
vious model. Hence, after a total of 48 h of infection,
BCG stimulated a sufficient output of soluble factors in
the CM, in both PBMC and CBMC cultures, to drive
additional 120 h of autologous monocyte cell-death. This
result, together with higher in vitro necrosis rate in the
UV group, is generally in line with our previous data
suggesting the distinct cell-death patterns induced by
BCG [8]. That was associated both with higher NO re-
leased from the BCG-primed group, but not from the
naïve individuals, and also by a distinct pattern of
additional mediators and cytokines that found a close
parallel to its respective cell-death outcome.
Reactive nitrogen intermediates, such as NO, have
been reported to possess anti-mycobacterial activity, and
it has long been established [13], as well as currently
understood, that NO is crucial in the host response
against intracellular pathogens [14]. Macrophages can
directly inhibit the proliferation of mycobacteria by pro-
ducing NO. In addition to the microbicidal properties,
NO is also important as signaling molecules and there-
fore promotes macrophage activation and prominent
apoptosis. This facilitates antigen presentation and helps
to connect the innate to the adaptive immune responses
[13, 14]. Hypothetically, the more apoptosis is induced
by a vaccine against TB in host cells, the more effective
is the response against M. tuberculosis. However, there is
insufficient evidence to determine whether NO is in-
volved in the defense against the TB bacillus in humans.
Here, the higher NO levels released after BCG infection
of mononuclears in the HD group, but not in the UV
group, might denote indirectly a memory phenotype that
remains active for years after priming, thus creating ef-
fective, long-lasting protection in those individuals. The
balance of cytokines that efficiently upregulate NO pro-
duction, such as IFN-γ, TNF-α and IL-1β, may play a
critical role in the defense mechanism against TB [19].
As above stated, IFN-γ synergizes with TNF-α for NO
production. Thus, our two previous in vitro studies cor-
roborate with the present one through lower NO levels
detected in neonate individuals: Virtually no IFN-γ pro-
duction [20] or TNF-α levels [8] were found in those as-
sessments. Therefore, studying human immune response
using the BCG Moreau vaccine and also including the
NO production may give us a better understanding of
the TB pathogenesis as well.
Resistance or susceptibility to a given infection is a com-
plex phenotype with a multifactorial trait, with several
critical candidates playing an important role. As an ex-
ample, arachidonic acid metabolites converted to the
eicosanoids PGE2 and LTB4 are inflammatory mediators
which are likely to be involved in apoptosis and necrosis
episodes, respectively. Originally, PGE2 was described as
the major prostanoid in the lung with an important antifi-
brotic role. On one hand, PGE2 mediates vasodilatation,
increases vascular permeability, enhances pain perception
by bradykinin and histamine, alters connective tissue
metabolism, and enhances osteoclastic bone resorption.
On the other hand, LTB4 causes the accumulation of in-
flammatory cells in the inflamed sites and degranulation
of polymorphonuclear leukocytes [21]. The preferential
synthesis of bioactive eicosanoids, mainly prostanoids, is a
critical branch point for the innate antimycobacterial
response of the infected macrophages. Distinct viru-
lence determinants can manipulate macrophage in-
flammation toward both extremes, both inducing
anti-inflammatory mediator production and also pro-
moting pro-inflammatory TNF [10]. More import-
antly, PGE2 was recently defined as a pro-apoptotic
host lipid mediator which protects against necrosis [9,
10]. In contrast, suppression of PGE2 synthesis by a
pronecrotic mediator results in mitochondrial damage
and inhibition of plasma membrane repair mecha-
nisms, ultimately leading to the induction of necrosis.
Thus, the balance between PGE2 and LTB4, presumably
another pronecrotic lipid intermediary, may actually de-
termine whether BCG-infected macrophages undergo
apoptosis or necrosis, and this balance determines the
outcome of infection. Accordingly, comparable to previ-
ous studies, we observed a significant pattern showing
that PGE2 and LTB4 were highly correlated to the corre-
sponding cell-death patterns; i.e. BCG-infected mononu-
clears induced PGE2 and apoptosis in both groups but
induced LTB4 and necrosis in the UV group only. Finally,
the absence of IL-1 decreases PGE2 in a model of M. tu-
berculosis-infected deficient mice, and the addition-of IL-1
or PGE2 reduces the bacteremia, whereas the TNF-
induced LTB4 rises in wild-type animals [18]. Additionally,
blocking of type I IFN signaling resulted in increased IL-1
and PGE2. Importantly, protection directly correlated with
higher PGE2 and lower type I IFN and IL1Ra production.
Likewise, PGE2 also inhibited type I IFN production in M.
tuberculosis-infected human macrophages. These findings
reveal that suppression of type I IFNs and their pro-
bacterial activity is a main mechanism of IL-1- and PGE2-
mediated host resistance against M. tuberculosis.
Similar to LTB4, IFN-β seems to be implicated earlier
in necrosis [16] and more recently in necroptosis [17].
In fact, one of the mechanisms underlying enhanced
susceptibility to bacterial infections is the stimulation of
IFN-β production, as stated above, and the latter study
showed a Salmonella enterica-induced macrophage death
via necroptosis in a type I IFN-dependent manner. That
novel cell-death modality is usually triggered by CD95 and
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TNF family of death receptors, and this programmed cell
necrosis is distinct from apoptosis [22]. In another setting,
pDCs were shown to be a major cell population producing
IFN-β through toll-like receptor (TLR) signaling [23].
Generally, pDCs produce most IFN-β within 48 h after
pathogen infection and then differentiate into mature DCs
with enhanced antigen-presenting capability, after which
they become refractory upon secondary stimulation and
lose their IFN-β production ability. Our current data of
highest IFN-β levels after that analogous period of BCG-
infected mononuclears in the UV group again shows this
cytokine to be well correlated with the necroptosis pattern
shown by Robinson and colleagues [17]. However, in our
system the exact underlying mechanism (necrosis vs.
necroptosis) has not yet been fully elucidated.
TGFβ1 might act as an anti-inflammatory arm prone to
damper Th1 immune response. Actually, in line with the
current data, our very recent study also failed to find any
Th3 cell phenotype induced by the BCG vaccine in the
sensitized adult cohort: Comparable TGFβ1 levels were
found regardless of the stimulus employed [24]. That study
originally established that the BCG Moreau vaccine in-
duced a significantly elevated IFN-γ/IL-10 ratio only in the
HD group, confirming a polarized Th1 pattern in vitro.
Based on those previous findings, our current primary
results suggest that apoptosis was again induced in
monocytes, probably via TNF and/or IL-1β in adults, but
not in neonates [8]. Of note, IL-1β drives PGE2 synthesis
in infected human macrophages [18]. However, we could
not rule out a role for other candidates, such as ATP,
TWEAK, TRAMP, TRAIL, and CD95, since there is a
long list of potential candidates for apoptosis induction
in our system, particularly for the new data regarding
naïve individuals [25].
Taking together, one could conclude that the apoptosis
pattern found in resting monocytes from both immu-
nized and naïve groups correlates well with high pro-
inflammatory cytokine levels induced in BCG-infected
mononuclears. However, necrosis data supports previous
findings in neonates only, but additional studies are war-
ranted to rule out other mechanisms such as pyroptosis
or necroptosis. These findings support the hypothesis
that BCG Moreau strain induces a milieu of soluble fac-
tors, which further stimulate distinct cell-death patterns
regarding the maturation of the immune system. This pat-
tern may set the stage for a subsequent anti-mycobacterial
immune response, which could have profound effects
during vaccination.
A possible unifying hypothesis on the central role of
cell-death modality in TB pathogenesis is that lesser apop-
tosis levels in BCG-infected monocytes of neonates could
predispose those individuals to the development of inflam-
matory disease due to lack of protective and specific im-
mune response. This is because only the phagocytosis of
apoptotic cells leads to the resolution of inflammation
[26]. Conversely, the progress to necrosis could predispose
those individuals to the development of disease, since
virulent M. tuberculosis inhibits apoptosis and triggers ne-
crosis of host macrophages, which delays the initiation of
adaptive immunity [9, 10]. Thus, BCG immunization is
the only pathway for increasing the immune response
against M. tuberculosis. On the other hand, BCG-
vaccinees show a balance between regulatory and effective
immune responses, and a breakdown in this equilibrium
would be crucial for TB development.
Despite some tantalizing clues and frequent overstate-
ments, the underlying immunological mechanisms by
which the BCG Moreau vaccine evokes protective im-
mune response against M. tuberculosis continues to be
poorly understood. The central puzzle that remains to be
deciphered is: How exactly does the BCG immunization
confer partial protection in the vaccinees?
Conclusion
In this study, BCG-infected macrophages from a naïve
group triggered PGE2, LTB4, and IFN-β levels, but BCG
triggered copious amount of NO and PGE2 in adults only.
Accordingly, BCG elicited a cell death modality leading to
cytolysis in infected macrophages from the naïve group
only. In striking contrast, apoptosis was found in the same
system in both groups studied. Taken together, our data is
in line with other studies demonstrating critical roles for
endogenous compounds, such as NO, PGE2, LTB4, IFN-β
and TGF-β1, in the regulation and induction of host
macrophage cell death patterns and their relevant role in
the modulation of inflammation. A better understanding
of the factors that protect against TB will help us identify
the processes by which this protection is achieved, thus
opening up a horizon for its future clinical applicability.
Ultimately, because prevention is still one of the best ap-
proaches to manage infectious diseases, this leads to the
development of improved prophylactic vaccines for TB
that, together with infectious diseases in general, dispro-
portionately affects poor and marginalized populations.
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(PGE2) and (B) leukotriene B4 (LTB4), in activity levels (%), and (C)
Transforming growth factor (TGF)-β1 levels, in pg/ml, and (D) Interferon
(IFN)-β levels, in IU/ml, in healthy donor (HD; n = 20) and umbilical vein
(UV; n = 6) groups representing baseline and different times of in vitro
BCG Moreau infection in human mononuclears. (PPT 51 kb)
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